ONDINE-LCNCT07081464
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 31 days later.
See at-risk trials from Assistance Publique - Hôpitaux de Paris
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 5 more changesShow less
- Eligibility criteria expanded, about 7 words
- Primary and study completion pushed from Oct 15, 2027 to Nov 15, 2027
- Start date changed from estimate of Oct 15, 2025 to Nov 15, 2025
- Study description revised
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Amplitude of the P300 wave (peak-to-baseline) recorded by high-resolution EEG during visual and auditory attention tasks.
Timeframe: 24 hours
Secondary (5)
Ratio of maximal pupil diameter during attention tasks to resting pupil diameter measured by pupillometry.
Functional connectivity parameters of the locus coeruleus measured by high-resolution EEG and 3T brain MRI diffusion imaging.
Scores of socio-adaptive behavior from the Vineland neuropsychological test (Vineland Adaptative Behavior Scales II, with scores ranging from 20 to 160; higher scores indicating better functioning).
Heart rate variability parameters from Holter ECG monitoring.
Structural connectivity parameters of the locus coeruleus measured by high-resolution EEG and 3T brain MRI diffusion imaging.
Arms and interventions
Subjects with severe Ondine syndrome (PHOX2B mutation with ≥ 27 alanine expansions)
Subjects with moderate Ondine syndrome (PHOX2B mutation with < 27 alanine expansions);
Other: MRI, EEG, Pupillometry
Sites
1 site in 1 country
- Robert Debré HospitalParis, Ap-hp / DRCI, France